HRMY

SEC source: 0001821460-26-000002 · form4-01262026_090155.xml · nonDerivative · entry 3

Serafin Andrew · CIK 0001821460 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0002009762-26-000002 · form4-01262026_090132.xml · derivative · entry 7

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,175

Underlying: Common Stock · 2,188 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F4 · derivative.exercise_price: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F4 · derivative.exercise_date: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F4 · derivative.expiration_date: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0002009762-26-000002 · form4-01262026_090132.xml · nonDerivative · entry 2

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,035

F1 · security: Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.

SEC source: 0002009762-26-000002 · form4-01262026_090132.xml · nonDerivative · entry 1

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,188

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001615993-26-000002 · form4-01262026_090130.xml · derivative · entry 7

Dayno Jeffrey M. · CIK 0001615993 · Director · PRESIDENT, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Common Stock · 10,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F4 · derivative.exercise_price: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F4 · derivative.exercise_date: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F4 · derivative.expiration_date: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0001615993-26-000002 · form4-01262026_090130.xml · nonDerivative · entry 2

Dayno Jeffrey M. · CIK 0001615993 · Director · PRESIDENT, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,715

F1 · security: Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.

SEC source: 0001615993-26-000002 · form4-01262026_090130.xml · nonDerivative · entry 1

Dayno Jeffrey M. · CIK 0001615993 · Director · PRESIDENT, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001677141-26-000002 · form4-01262026_090157.xml · derivative · entry 7

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,625

Underlying: Common Stock · 3,813 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F4 · derivative.exercise_price: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F4 · derivative.exercise_date: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F4 · derivative.expiration_date: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0001677141-26-000002 · form4-01262026_090157.xml · nonDerivative · entry 2

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,574

F1 · security: Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.

SEC source: 0001677141-26-000002 · form4-01262026_090157.xml · nonDerivative · entry 1

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,813

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001821460-26-000002 · form4-01262026_090155.xml · derivative · entry 7

Serafin Andrew · CIK 0001821460 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 2,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F4 · derivative.exercise_price: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F4 · derivative.exercise_date: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F4 · derivative.expiration_date: This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0001821460-26-000002 · form4-01262026_090155.xml · nonDerivative · entry 2

Serafin Andrew · CIK 0001821460 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,384

F1 · security: Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.

SEC source: 0001821460-26-000002 · form4-01262026_090155.xml · nonDerivative · entry 1

Serafin Andrew · CIK 0001821460 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0002009762-26-000002 · form4-01262026_090132.xml · derivative · entry 6

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,200

Underlying: Common Stock · 12,200 shares

Expires not disclosed

F3 · derivative.exercise_price: The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F3 · derivative.exercise_date: The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F3 · derivative.expiration_date: The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0002009762-26-000002 · form4-01262026_090132.xml · derivative · entry 5

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,600

Underlying: Common Stock · 42,600 shares

Expires 2036-01-22

F2 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001615993-26-000002 · form4-01262026_090130.xml · derivative · entry 6

Dayno Jeffrey M. · CIK 0001615993 · Director · PRESIDENT, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,900

Underlying: Common Stock · 52,900 shares

Expires not disclosed

F3 · derivative.exercise_price: The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F3 · derivative.exercise_date: The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F3 · derivative.expiration_date: The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0001615993-26-000002 · form4-01262026_090130.xml · derivative · entry 5

Dayno Jeffrey M. · CIK 0001615993 · Director · PRESIDENT, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,600

Underlying: Common Stock · 184,600 shares

Expires 2036-01-22

F2 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001677141-26-000002 · form4-01262026_090157.xml · derivative · entry 6

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,200

Underlying: Common Stock · 12,200 shares

Expires not disclosed

F3 · derivative.exercise_price: The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F3 · derivative.exercise_date: The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F3 · derivative.expiration_date: The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0001677141-26-000002 · form4-01262026_090157.xml · derivative · entry 5

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,600

Underlying: Common Stock · 42,600 shares

Expires 2036-01-22

F2 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001821460-26-000002 · form4-01262026_090155.xml · derivative · entry 6

Serafin Andrew · CIK 0001821460 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,200

Underlying: Common Stock · 12,200 shares

Expires not disclosed

F3 · derivative.exercise_price: The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F3 · derivative.exercise_date: The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F3 · derivative.expiration_date: The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0001821460-26-000002 · form4-01262026_090155.xml · derivative · entry 5

Serafin Andrew · CIK 0001821460 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,600

Underlying: Common Stock · 42,600 shares

Expires 2036-01-22

F2 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0002064712-26-000002 · form4-01262026_090126.xml · derivative · entry 2

Zaeske Adam H. · CIK 0002064712 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,200

Underlying: Common Stock · 16,200 shares

Expires not disclosed

F2 · derivative.exercise_price: The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F2 · derivative.exercise_date: The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F2 · derivative.expiration_date: The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0002064712-26-000002 · form4-01262026_090126.xml · derivative · entry 1

Zaeske Adam H. · CIK 0002064712 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,900

Underlying: Common Stock · 56,900 shares

Expires 2036-01-22

F1 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001677141-26-000001 · form4-01212026_010111.xml · nonDerivative · entry 1

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.68 to $36.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001615993-25-000005 · form4-12172025_051201.xml · derivative · entry 4

Dayno Jeffrey M. · CIK 0001615993 · Director · PRESIDENT, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2027-11-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option vests in five equal annual installments beginning on November 1, 2018.

SEC source: 0001615993-25-000005 · form4-12172025_051201.xml · nonDerivative · entry 3

Dayno Jeffrey M. · CIK 0001615993 · Director · PRESIDENT, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.28. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001615993-25-000005 · form4-12172025_051201.xml · nonDerivative · entry 2

Dayno Jeffrey M. · CIK 0001615993 · Director · PRESIDENT, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.28. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001615993-25-000005 · form4-12172025_051201.xml · nonDerivative · entry 1

Dayno Jeffrey M. · CIK 0001615993 · Director · PRESIDENT, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001677141-25-000008 · form4-12092025_041201.xml · derivative · entry 3

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 185,000

Underlying: Common Stock · 20,000 shares

Expires 2031-03-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option shall vest with respect to 50% of the underlying shares on March 23, 2023 and with respect to the remaining shares, in twenty-four equal monthly installments beginning on April 23, 2023.

SEC source: 0001677141-25-000008 · form4-12092025_041201.xml · nonDerivative · entry 2

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $39.63. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001677141-25-000008 · form4-12092025_041201.xml · nonDerivative · entry 1

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001677141-25-000006 · form4-11252025_041102.xml · nonDerivative · entry 1

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001677141-25-000004 · form4-10022025_041003.xml · derivative · entry 3

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F2 · derivative.exercise_date: The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F2 · derivative.expiration_date: The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0001677141-25-000004 · form4-10022025_041003.xml · nonDerivative · entry 2

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,961

F1 · security: Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.

SEC source: 0001677141-25-000004 · form4-10022025_041003.xml · nonDerivative · entry 1

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-25-083535 · ownership.xml · nonDerivative · entry 1

Valor IV Pharma Holdings, LLC · CIK 0001821186 · 10% owner

Valor Management L.P. · CIK 0001822428 · 10% owner

Valor Equity Capital IV LLC · CIK 0001821936 · 10% owner

Valor Equity Associates IV L.P. · CIK 0001822427 · 10% owner

VALOR EQUITY PARTNERS IV L.P. · CIK 0001705506 · 10% owner

VALOR EQUITY PARTNERS IV-A L.P. · CIK 0001705542 · 10% owner

VALOR EQUITY PARTNERS IV-B L.P. · CIK 0001705512 · 10% owner

Gracias Antonio J. · CIK 0001495158 · Director · 10% owner

Sabater Juan A. · CIK 0001821210 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: In-kind pro rata distribution by Valor IV Pharma Holdings, LLC, without consideration.

F1 · price: In-kind pro rata distribution by Valor IV Pharma Holdings, LLC, without consideration.

SEC source: 0001415889-25-022294 · form4-08192025_040801.xml · nonDerivative · entry 1

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.11 to $36.87. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001415889-25-013399 · form4-05162025_080552.xml · derivative · entry 1

Graf R. Mark · CIK 0001494757 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,522

Underlying: Common Stock · 14,522 shares

Expires 2035-05-15

F1 · derivative.exercise_date: The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001415889-25-013405 · form4-05162025_080525.xml · derivative · entry 1

Philip Ron M · CIK 0002063957 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,522

Underlying: Common Stock · 14,522 shares

Expires 2035-05-15

F1 · derivative.exercise_date: The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001415889-25-013401 · form4-05162025_080533.xml · derivative · entry 1

Anastasiou Peter · CIK 0001999888 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,522

Underlying: Common Stock · 14,522 shares

Expires 2035-05-15

F1 · derivative.exercise_date: The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001415889-25-013409 · form4-05162025_080525.xml · derivative · entry 1

Gracias Antonio J. · CIK 0001495158 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,522

Underlying: Common Stock · 14,522 shares

Expires 2035-05-15

F1 · derivative.exercise_date: 1. The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001415889-25-013397 · form4-05162025_080517.xml · derivative · entry 1

Sender Gary · CIK 0001659085 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,522

Underlying: Common Stock · 14,522 shares

Expires 2035-05-15

F1 · derivative.exercise_date: The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001415889-25-013403 · form4-05162025_080514.xml · derivative · entry 1

Szyper Linda M · CIK 0001739050 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,522

Underlying: Common Stock · 14,522 shares

Expires 2035-05-15

F1 · derivative.exercise_date: 1. The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001415889-25-013411 · form4-05162025_080555.xml · derivative · entry 1

Sabater Juan A. · CIK 0001821210 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,522

Underlying: Common Stock · 14,522 shares

Expires 2035-05-15

F1 · derivative.exercise_date: 1. The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001415889-25-012477 · form4-05092025_080555.xml · derivative · entry 3

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,750

Underlying: Common Stock · 18,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F2 · derivative.exercise_date: The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F2 · derivative.expiration_date: The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0001415889-25-012477 · form4-05092025_080555.xml · nonDerivative · entry 2

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,881

F1 · security: Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.

SEC source: 0001415889-25-012477 · form4-05092025_080555.xml · nonDerivative · entry 1

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-25-010798 · form4-04162025_080447.xml · derivative · entry 2

Zaeske Adam H. · CIK 0002064712 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F2 · derivative.exercise_price: The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F2 · derivative.exercise_date: The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F2 · derivative.expiration_date: The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0001415889-25-010798 · form4-04162025_080447.xml · derivative · entry 1

Zaeske Adam H. · CIK 0002064712 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2035-04-07

F1 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on April 7, 2026, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001415889-25-010247 · form4-04042025_090430.xml · derivative · entry 1

Philip Ron M · CIK 0002063957 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,077

Underlying: Common Stock · 14,077 shares

Expires 2035-04-02

F1 · derivative.exercise_date: The stock option shall vest in 36 equal monthly installments beginning on May 2, 2025.